Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial

Andreas Metzner; Anna Suling; Axel Brandes; Günter Breithardt; A John Camm; Harry J G M Crijns; Lars Eckardt; Arif Elvan; Andreas Goette; Laurent M Haegeli; Hein Heidbuchel; Josef Kautzner; Karl-Heinz Kuck; Luis Mont; A Andre Ng; Lukasz Szumowski; Sakis Themistoclakis; Isabelle C van Gelder; Panos Vardas; Karl Wegscheider; Stephan Willems; Paulus Kirchhof

doi:10.1093/europace/euab200

Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial

Andreas Metzner, Anna Suling, Axel Brandes, Günter Breithardt, A John Camm, Harry J G M Crijns, Lars Eckardt, Arif Elvan, Andreas Goette, Laurent M Haegeli, Hein Heidbuchel, Josef Kautzner, Karl-Heinz Kuck, Luis Mont, A Andre Ng, Lukasz Szumowski, Sakis Themistoclakis, Isabelle C van Gelder, Panos Vardas, Karl WegscheiderStephan Willems, Paulus Kirchhof^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Web of Science)

Original language	English
Pages (from-to)	552-564
Number of pages	13
Journal	EP Europace
Volume	24
Issue number	4
Early online date	2 Sep 2021
DOIs	https://doi.org/10.1093/europace/euab200
Publication status	Published - 5 Apr 2022

Keywords

Atrial fibrillation
Anticoagulation
Rhythm control therapy
Antiarrhythmic drugs
Ablation
Stroke
Cardiovascular death
Heart failure
2010 ESC GUIDELINES
ATRIAL-FIBRILLATION
ORAL ANTICOAGULANTS
EUROPEAN COUNTRIES
MANAGEMENT
PREVENTION
ABLATION

Access to Document

10.1093/europace/euab200

Cite this

Metzner, A., Suling, A., Brandes, A., Breithardt, G., Camm, A. J., Crijns, H. J. G. M., Eckardt, L., Elvan, A., Goette, A., Haegeli, L. M., Heidbuchel, H., Kautzner, J., Kuck, K-H., Mont, L., Ng, A. A., Szumowski, L., Themistoclakis, S., van Gelder, I. C., Vardas, P., ... Kirchhof, P. (2022). Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial. EP Europace, 24(4), 552-564. https://doi.org/10.1093/europace/euab200

Metzner, Andreas ; Suling, Anna ; Brandes, Axel ; Breithardt, Günter ; Camm, A John ; Crijns, Harry J G M ; Eckardt, Lars ; Elvan, Arif ; Goette, Andreas ; Haegeli, Laurent M ; Heidbuchel, Hein ; Kautzner, Josef ; Kuck, Karl-Heinz ; Mont, Luis ; Ng, A Andre ; Szumowski, Lukasz ; Themistoclakis, Sakis ; van Gelder, Isabelle C ; Vardas, Panos ; Wegscheider, Karl ; Willems, Stephan ; Kirchhof, Paulus. / Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy : a detailed analysis of treatment patterns in the EAST - AFNET 4 trial. In: EP Europace. 2022 ; Vol. 24, No. 4. pp. 552-564.

@article{436dc03f4f2f45669a13a6e4f1e69f56,

title = "Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial",

keywords = "Atrial fibrillation, Anticoagulation, Rhythm control therapy, Antiarrhythmic drugs, Ablation, Stroke, Cardiovascular death, Heart failure, 2010 ESC GUIDELINES, ATRIAL-FIBRILLATION, ORAL ANTICOAGULANTS, EUROPEAN COUNTRIES, MANAGEMENT, PREVENTION, ABLATION",

author = "Andreas Metzner and Anna Suling and Axel Brandes and G{\"u}nter Breithardt and Camm, {A John} and Crijns, {Harry J G M} and Lars Eckardt and Arif Elvan and Andreas Goette and Haegeli, {Laurent M} and Hein Heidbuchel and Josef Kautzner and Karl-Heinz Kuck and Luis Mont and Ng, {A Andre} and Lukasz Szumowski and Sakis Themistoclakis and {van Gelder}, {Isabelle C} and Panos Vardas and Karl Wegscheider and Stephan Willems and Paulus Kirchhof",

note = "{\textcopyright} The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.",

year = "2022",

month = apr,

day = "5",

doi = "10.1093/europace/euab200",

language = "English",

volume = "24",

pages = "552--564",

journal = "EP Europace",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "4",

}

Metzner, A, Suling, A, Brandes, A, Breithardt, G, Camm, AJ, Crijns, HJGM, Eckardt, L, Elvan, A, Goette, A, Haegeli, LM, Heidbuchel, H, Kautzner, J, Kuck, K-H, Mont, L, Ng, AA, Szumowski, L, Themistoclakis, S, van Gelder, IC, Vardas, P, Wegscheider, K, Willems, S & Kirchhof, P 2022, 'Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial', EP Europace, vol. 24, no. 4, pp. 552-564. https://doi.org/10.1093/europace/euab200

Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy : a detailed analysis of treatment patterns in the EAST - AFNET 4 trial. / Metzner, Andreas; Suling, Anna; Brandes, Axel; Breithardt, Günter; Camm, A John; Crijns, Harry J G M; Eckardt, Lars; Elvan, Arif; Goette, Andreas; Haegeli, Laurent M; Heidbuchel, Hein; Kautzner, Josef; Kuck, Karl-Heinz; Mont, Luis; Ng, A Andre; Szumowski, Lukasz; Themistoclakis, Sakis; van Gelder, Isabelle C; Vardas, Panos; Wegscheider, Karl; Willems, Stephan; Kirchhof, Paulus.

In: EP Europace, Vol. 24, No. 4, 05.04.2022, p. 552-564.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy

T2 - a detailed analysis of treatment patterns in the EAST - AFNET 4 trial

AU - Metzner, Andreas

AU - Suling, Anna

AU - Brandes, Axel

AU - Breithardt, Günter

AU - Camm, A John

AU - Crijns, Harry J G M

AU - Eckardt, Lars

AU - Elvan, Arif

AU - Goette, Andreas

AU - Haegeli, Laurent M

AU - Heidbuchel, Hein

AU - Kautzner, Josef

AU - Kuck, Karl-Heinz

AU - Mont, Luis

AU - Ng, A Andre

AU - Szumowski, Lukasz

AU - Themistoclakis, Sakis

AU - van Gelder, Isabelle C

AU - Vardas, Panos

AU - Wegscheider, Karl

AU - Willems, Stephan

AU - Kirchhof, Paulus

N1 - © The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

PY - 2022/4/5

Y1 - 2022/4/5

KW - Atrial fibrillation

KW - Anticoagulation

KW - Rhythm control therapy

KW - Antiarrhythmic drugs

KW - Ablation

KW - Stroke

KW - Cardiovascular death

KW - Heart failure

KW - 2010 ESC GUIDELINES

KW - ATRIAL-FIBRILLATION

KW - ORAL ANTICOAGULANTS

KW - EUROPEAN COUNTRIES

KW - MANAGEMENT

KW - PREVENTION

KW - ABLATION

U2 - 10.1093/europace/euab200

DO - 10.1093/europace/euab200

M3 - Article

C2 - 34473249

VL - 24

SP - 552

EP - 564

JO - EP Europace

JF - EP Europace

SN - 1099-5129

IS - 4

ER -